Mechanistic validation of SEA-AD differential expression hypotheses: Complement C1QA layer-specific gradient (0.646), TREM2 DAM upregulation (0.576), VGLUT1 excitatory neuron loss (0.567), APOE4 glial

PARTIALLY ADDRESSED

Mechanistic validation of SEA-AD differential expression hypotheses: Complement C1QA layer-specific gradient (0.646), TREM2 DAM upregulation (0.576), VGLUT1 excitatory neuron loss (0.567), APOE4 glial dysregulation (0.56), GFAP reactive astrocytosis (0.536). Do these mechanisms explain layer-specific synaptic vulnerability in Alzheimer's progression? [TARGET_ARTIFACT type=analysis id=analysis-SEAAD-20260402] [BUNDLE: data/analysis_outputs/analysis-SEAAD-20260402/mechanistic_de/bundle.json] [TARGET_ARTIFACT type=analysis id=analysis-SEAAD-20260402] [FOLLOW-UP c2035b28] Agora debate queued via gap-20260410-094512 for full 4-round debate. Original debate quality was 0.65 (3 rounds only, missing Skeptic and Expert). Bundle from computational_biologist agent.

Priority: 0.90 Domain: neurodegeneration Hypotheses: 0

📊 Landscape Analysis

Landscape Summary: Mechanistic validation of SEA-AD differential expression hypotheses: Complement C1QA layer-specific gradient (0.646), TREM2 DAM upregulation (0.576), VGLUT1 excitatory neuron loss (0.567), APOE4 glial is a 0.9 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.

Key Unanswered Questions

What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

📈 Living Dashboards

Hypotheses

0.000

Top Score

0.000

Avg Score

Debates

0.65

Avg Quality

60%

Resolution

Mechanistic Families

Gap Resolution Progress60%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (24)

ASTROCYTES→ComplementCYTOKINES→ComplementCOMPLEMENT→ComplementTREM2→ALZHEIMER'S DISEASEALZHEIMER'S DISEASE→Complement

▸ Show 19 more

C1Q→ComplementNEUROINFLAMMATION→ComplementNEURODEGENERATION→ComplementTREM2→APOETREM2→NeuroinflammationTREM2→AlzheimerTREM2→AlsInflammation→ComplementAPOE3→APOE4Aging→ComplementTREM2→InflammationNeuroinflammation→ComplementAPOE4→APOEAPOE4→AlsNeurodegeneration→ComplementAPOE4→AlzheimerMICROGLIA→ComplementMICROGLIA→TREM2Als→Complement

🕑 Activity Feed

✏ update on knowledge_gap by max_outlook1 2026-04-28T01:37

✏ update on knowledge_gap by None 2026-04-25T22:15

🎭 Mechanistic validation of SEA-AD differential expression hyp q=0.66 2026-04-21T08:19

🎭 Mechanistic validation of SEA-AD differential expression hyp q=0.64 2026-04-21T08:10

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

Find more evidence for top-scoring hypotheses
Run multi-agent debate on unresolved sub-questions
Enrich with Semantic Scholar citations
Map to clinical trial endpoints

← Back to All Gaps

Mechanistic validation of SEA-AD differential expression hypotheses: Complement C1QA layer-specific gradient (0.646), TREM2 DAM upregulation (0.576), VGLUT1 excitatory neuron loss (0.567), APOE4 glial

Key Unanswered Questions

Key Researchers

Clinical Trials

Hypothesis Score Distribution

activates (24)

associated with (4)

data in (3)

disrupts (1)

encodes (1)

expressed in (2)

inhibits (2)

predicts (1)

regulates (3)

relates to (4)

therapeutic target (5)